✦ LIBER ✦

Predicting drug-resistant patients who respond to add-on therapy with levetiracetam

✍ Scribed by P. Kinirons; M. McCarthy; C.P. Doherty; N. Delanty

Book ID: 116880227
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 93 KB
Volume: 15
Category: Article
ISSN: 1059-1311
DOI: 10.1016/j.seizure.2006.05.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sa1064 Baseline Hematologic Indices With

Sa1064 Baseline Hematologic Indices With Albumin Predict Clinical Decompensation in Patients With HCV Cirrhosis Who Do Not Respond to Antiviral Therapy

✍ Karagozian, Raffi; Grace, Norman D.; Qamar, Amir A. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 425 KB

Long-term outcomes of add-on adefovir di

Long-term outcomes of add-on adefovir dipivoxil therapy to ongoing lamivudine in patients with lamivudine-resistant chronic hepatitis B

✍ Takashi Toyama; Hisashi Ishida; Hiromi Ishibashi; Hiroshi Yatsuhashi; Makoto Nak 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 203 KB

Efficacy of adefovir add-on lamivudine r

Efficacy of adefovir add-on lamivudine rescue therapy compared with switching to entecavir monotherapy in patients with lamivudine-resistant chronic hepatitis B

✍ Han Jak Ryu; Jung Min Lee; Sang Hoon Ahn; Do Young Kim; Myoung Ha Lee; Kwang-Hyu 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 1 views

## Abstract No study has reported on the comparative effect of adefovir (ADV) add‐on lamivudine (LAM) versus switching to entecavir (ETV) in LAM‐resistant patients with chronic hepatitis B. From October 2007 to September 2008, 92 consecutive LAM‐resistant patients were enrolled (47 LAM + ADV and 45

Alternative monotherapy or add-on therap

Alternative monotherapy or add-on therapy in patients with epilepsy whose seizures do not respond to the first monotherapy: An Italian multicenter prospective observational study

✍ Millul, Andrea; Iudice, Alfonso; Adami, Marina; Porzio, Roberto; Mattana, Flavia 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 294 KB

One-year maintenance outcomes among pati

One-year maintenance outcomes among patients with moderately-to-severely active ulcerative colitis who responded to induction therapy with adalimumab: subgroup analyses from ULTRA 2

✍ Sandborn, W. J.; Colombel, J.-F.; D'Haens, G.; Van Assche, G.; Wolf, D.; Kron, M 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 386 KB

Evaluation of stepwise insulin treatment

Evaluation of stepwise insulin treatment as an add-on to current oral antidiabetic drugs therapy in Japanese patients with type 2 diabetes: STEADY study

✍ Tomoko Nakagami, Masashi Honda, Naomi Shibata, Osamu Tomonaga… 📂 Article 📅 2013 🏛 Springer Japan 🌐 English ⚖ 399 KB